Nobel Award Recognizes Pioneering Immune System Research
The Nobel Prize in medical science was granted for transformative findings that clarify how the body's defense network targets harmful infections while sparing the healthy tissues.
Three renowned scientists—Japan's Shimon Sakaguchi and American scientists Dr. Brunkow and Dr. Ramsdell—share this honor.
The research uncovered specialized "sentinels" within the defense system that remove malfunctioning immune cells capable of harming the body.
These findings are now paving the way for new therapies for autoimmune diseases and cancer.
The winners will divide a prize fund worth 11m Swedish kronor.
Crucial Findings
"Their work has been decisive for comprehending how the body's defenses functions and the reason we do not all develop serious autoimmune diseases," commented the head of the award panel.
The trio's studies address a core mystery: In what way does the immune system defend us from numerous invaders while leaving our own tissues intact?
Our body's protection system uses immune cells that scan for signs of infection, even pathogens and bacteria it has not met before.
These defenders utilize detectors—known as recognition units—that are generated by chance in countless combinations.
That provides the immune system the capacity to combat a wide array of threats, but the unpredictability of the process unavoidably creates immune cells that may attack the body.
Security Guards of the Immune System
Researchers earlier knew that a portion of these problematic defense cells were destroyed in the thymus—where white blood cells develop.
The latest award recognizes the identification of T-reg cells—described as the body's "security guards"—which patrol the body to disarm any immune cells that assault the healthy cells.
We know that this mechanism malfunctions in self-attack conditions such as type-1 diabetes, MS, and RA.
The prize committee added, "The discoveries have laid the foundation for a new field of investigation and spurred the development of new treatments, for instance for cancer and autoimmune diseases."
In cancer, regulatory T-cells block the body from fighting the growth, so research are aimed at lowering their numbers.
In autoimmune diseases, experiments are exploring boosting regulatory T-cells so the body is not under attack. A comparable approach could also be effective in reducing the risks of transplanted organ failure.
Pioneering Experiments
Professor Sakaguchi, of Osaka University, conducted experiments on rodents that had their thymus removed, leading to autoimmune disease.
He demonstrated that introducing immune cells from other mice could prevent the illness—suggesting there was a mechanism for preventing immune cells from harming the body.
Dr. Brunkow, affiliated with the a research center in Seattle, and Fred Ramsdell, currently at a biotech firm in a California city, were studying an genetic immune disorder in rodents and people that led to the discovery of a genetic factor vital for how regulatory T-cells operate.
"The groundbreaking research has uncovered how the immune system is controlled by regulatory T cells, preventing it from accidentally targeting the healthy cells," said a prominent physiology specialist.
"This work is a striking illustration of how fundamental physiological study can have broad implications for public health."
